Wednesday, November 23, 2011

TEVA - New Position

A new CSP position was established today on Teva Pharmaceutical Industries Ltd (TEVA). All prices include IB commissions.

Note: This is the second position on TEVA.

Dividend Champions StatusContender
Years of Consecutive Dividend Increases12
Fair Value Estimate$58.00
Target Buy Price$40.60
Target Margin of Safety30.00%
Actual Buy Price$35.00
Actual Margin of Safety39.66%

DateStockDescriptionTransactionStatusStock InvestmentIncome Generated
11/23/2011TEVACSP Margin UsedCSP 100 TEVA @ 35.00 ($3,500.00) 
11/23/2011TEVAInitial Put OptionSTO 1 Jan12 35.00 Put @ 1.01  $100.98

Position Summary

Cost Basis($3,500.00)
Income Generated$100.98
Percent Income Generated2.89%
Annualized Income Generated18.16%
Net Profit If Assigned$100.98
Percent Return If Assigned2.89%
Annualized Return If Assigned18.16%
Days Held to Expiration58 days